methamphetamine has been researched along with Heritable Pulmonary Arterial Hypertension in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| De Marco, T; Kolaitis, NA; Saggar, R | 1 |
| Badesch, DB; Benza, RL; Burger, CD; Chakinala, MM; de Jesus Perez, VA; De Marco, T; Elwing, JM; Feldman, J; Glidden, DV; Kawut, SM; Kolaitis, NA; Lammi, MR; Mathai, SC; McConnell, JW; Presberg, KW; Robinson, JC; Sager, J; Shlobin, OA; Simon, MA; Singer, JP; Zamanian, RT | 1 |
| Machado, RF; Prohaska, CC | 1 |
| Humbert, M; Simonneau, G | 2 |
| Frachon, I | 1 |
| Bai, Y; Liu, M; Sun, YX; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
| Cogswell, R; De Marco, T; Kobashigawa, E; McGlothlin, D; Shaw, R | 1 |
1 review(s) available for methamphetamine and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Methamphetamine-associated pulmonary arterial hypertension.
Topics: Amphetamine-Related Disorders; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine; Pulmonary Arterial Hypertension; Quality of Life | 2022 |
7 other study(ies) available for methamphetamine and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Topics: Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine; Prospective Studies; Quality of Life; Registries; United States | 2021 |
Regional Variation in Methamphetamine-associated Pulmonary Arterial Hypertension: Who'd Better Call Saul?
Topics: Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine; Pulmonary Arterial Hypertension; Registries | 2021 |
Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension. A New Chapter of the Story.
Topics: Amphetamine; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine | 2018 |
Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?
Topics: Amphetamine; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine | 2018 |
Reply to Frachon: Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?
Topics: Amphetamine; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Methamphetamine | 2018 |
Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
Topics: Amphetamine-Related Disorders; Animals; Antidepressive Agents, Second-Generation; Down-Regulation; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Lung; Male; Methamphetamine; Pulmonary Artery; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Serotonin Plasma Membrane Transport Proteins | 2013 |
Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival.
Topics: Adult; Aged; Comorbidity; Disease Management; Familial Primary Pulmonary Hypertension; Female; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Lung Transplantation; Male; Methamphetamine; Middle Aged; Models, Statistical; Registries; Retrospective Studies; Substance-Related Disorders; Survival Rate; Time Factors | 2012 |